Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie Wilson

Showing results (61-70 of 179) with videos related to

Pageof 18
Sort By:
Methods in Cell Biology|September 9, 2017
Digital quantification of neurite outgrowth and retraction by phase-contrast microscopy: A tau perspectiveBrett Cook, Duncan Proctor, Rachel Bromberg, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 22, 2025
Diabetes disparities in diabetes health care access and outcomes during the COVID-19 pandemic in the United StatesLixian Zhong, Yanlei Ma, Yelena Ionova, et al.
Journal of Cardiovascular Electrophysiology|April 17, 2020
A cost-effectiveness analysis comparing a conventional mechanical needle to a radiofrequency device for transseptal puncturesJosé M Sanchez, Rahil Shah, Yao Kouassi, et al.
Molecular Cell|September 24, 2004
Inhibition of DNA decatenation, but not DNA damage, arrests cells at metaphaseDimitrios A Skoufias, Françoise B Lacroix, Paul R Andreassen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 28, 2015
Cost-Effectiveness and Value of Information of Erlotinib, Afatinib, and Cisplatin-Pemetrexed for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer in the United StatesJie Ting, PharmD Tien Ho, Pin Xiang, et al.
Translational Vision Science & Technology|March 28, 2023
Systemic Administration of Acazicolcept, a Dual CD28 and Inducible T cell Costimulator Inhibitor, Ameliorates Experimental Autoimmune UveitisLeslie Wilson, Katherine E Lewis, Lawrence S Evans, et al.
Phytotherapy Research : PTR|June 24, 2009
Hesperidin suppressed proliferations of both human breast cancer and androgen-dependent prostate cancer cellsChoong Jae Lee, Leslie Wilson, Mary Ann Jordan, et al.
Clinical Drug Investigation|May 23, 2022
Cost-Effectiveness Analysis of Atezolizumab Versus Durvalumab as First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer in the USAYelena Ionova, Wilson Vuong, Omar Sandoval, et al.
American Journal of Clinical Oncology|January 6, 2022
A Cost-effectiveness Analysis Comparing Pembrolizumab-Axitinib, Nivolumab-Ipilimumab, and Sunitinib for Treatment of Advanced Renal Cell CarcinomaAlan Chan, Carolyn Dang, Jessica Wisniewski, et al.
Chemistry & Biology|February 14, 2002
Effects of novel taxanes SB-T-1213 and IDN5109 on tubulin polymerization and mitosisMary Ann Jordan, Iwao Ojima, Francisco Rosas, et al.
Pageof 18

Showing results (61-70 of 179) with videos related to

Sort By:
Pageof 18
Methods in Cell Biology|September 9, 2017
Digital quantification of neurite outgrowth and retraction by phase-contrast microscopy: A tau perspectiveBrett Cook, Duncan Proctor, Rachel Bromberg, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 22, 2025
Diabetes disparities in diabetes health care access and outcomes during the COVID-19 pandemic in the United StatesLixian Zhong, Yanlei Ma, Yelena Ionova, et al.
Journal of Cardiovascular Electrophysiology|April 17, 2020
A cost-effectiveness analysis comparing a conventional mechanical needle to a radiofrequency device for transseptal puncturesJosé M Sanchez, Rahil Shah, Yao Kouassi, et al.
Molecular Cell|September 24, 2004
Inhibition of DNA decatenation, but not DNA damage, arrests cells at metaphaseDimitrios A Skoufias, Françoise B Lacroix, Paul R Andreassen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 28, 2015
Cost-Effectiveness and Value of Information of Erlotinib, Afatinib, and Cisplatin-Pemetrexed for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer in the United StatesJie Ting, PharmD Tien Ho, Pin Xiang, et al.
Translational Vision Science & Technology|March 28, 2023
Systemic Administration of Acazicolcept, a Dual CD28 and Inducible T cell Costimulator Inhibitor, Ameliorates Experimental Autoimmune UveitisLeslie Wilson, Katherine E Lewis, Lawrence S Evans, et al.
Phytotherapy Research : PTR|June 24, 2009
Hesperidin suppressed proliferations of both human breast cancer and androgen-dependent prostate cancer cellsChoong Jae Lee, Leslie Wilson, Mary Ann Jordan, et al.
Clinical Drug Investigation|May 23, 2022
Cost-Effectiveness Analysis of Atezolizumab Versus Durvalumab as First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer in the USAYelena Ionova, Wilson Vuong, Omar Sandoval, et al.
American Journal of Clinical Oncology|January 6, 2022
A Cost-effectiveness Analysis Comparing Pembrolizumab-Axitinib, Nivolumab-Ipilimumab, and Sunitinib for Treatment of Advanced Renal Cell CarcinomaAlan Chan, Carolyn Dang, Jessica Wisniewski, et al.
Chemistry & Biology|February 14, 2002
Effects of novel taxanes SB-T-1213 and IDN5109 on tubulin polymerization and mitosisMary Ann Jordan, Iwao Ojima, Francisco Rosas, et al.
Pageof 18